You are browsing articles on the topic of General Archives - CardioExchange

Avatar of Saurav

Networking Opportunities and Cardiology Bootcamp at ACC.15 (18 Mar 2015)

Voices

Saurav Chatterjee, MD

Saurav Chatterjee reports from the 2015 ACC conference with even more exciting opportunities for fellows in training and other health care professionals.

Avatar of Saurav

Learning Opportunities for Fellows-in-Training at ACC 2015 (16 Mar 2015)

Voices

Saurav Chatterjee, MD

Saurav Chatterjee reports on exciting opportunities for fellows in training available at the 2015 ACC conference.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: March 16th (16 Mar 2015)

Voices

Richard Lehman, BM, BCh, MRCGP

This week’s topics include endovascular therapy for ischemic stroke with perfusion-imaging selection, innovation and implementation in CV medicine, statin intolerance, and more.

Avatar of Larry Husten, PHD

More Information Emerges About the PCSK9 Inhibitors (15 Mar 2015)

News

New information emerged today about two new cholesterol-lowering drugs that have been attracting a lot of attention. Data about the PCSK9 inhibitors — evolocumab, under development by Amgen, and alirocumab, under development by Sanofi and Regeneron — were presented at the American College of Cardiology meeting in San Diego and published simultaneously in the New England Journal of…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Has CT Angiography Lived Up to Its Early Promise? (14 Mar 2015)

News

Computed tomographic angiography (CTA) enjoyed an explosion of growth over the past decade or more, fueled by enthusiasm for its ability to deliver speedy, high-resolution images of the coronary arteries. Many anticipated that CTA would prove its worth and justify its expense and radiation dose. As explained by one cardiologist, Duke University’s Dan Mark, with…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of CardioExchange Administrator, Staff

ACC.15 Headquarters (14 Mar 2015)

Voices

CardioExchange Administrator, Staff

As ACC.15 unfolds, check our Headquarters page for all of our latest coverage!

Avatar of Pamela S. Douglas, MD

Assessing the Diagnostic PROMISE of CT Angiography (14 Mar 2015)

Voices

Pamela S. Douglas, MD

Pamela S. Douglas discusses the PROMISE randomized comparison of CT angiography with functional exercise testing in more than 10,000 patients with chest pain.

Avatar of Larry Husten, PHD

DAPT ‘Approaching the Point of Diminishing Returns’? (14 Mar 2015)

News

After a myocardial infarction (MI), patients remain at high risk for recurrent events. The precise role of dual antiplatelet therapy (DAPT) to lower this risk has been the subject of considerable disagreement.  Now a new study offers fresh evidence that prolonged DAPT can lower risk over a long period, but only at the cost of…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

FDA Approves Watchman Left Atrial Appendage Closure Device for AF (14 Mar 2015)

News

The FDA has approved Boston Scientific’s long-delayed Watchman Left Atrial Appendage Closure Device. According to the company, the Watchman is indicated as an alternative to long-term warfarin therapy for the reduction of thromboembolism from the left atrial appendage in patients with non-valvular atrial fibrillation at increased risk for stroke and systemic embolism. Although an alternative to…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

First Good Look at TAVR in The Real World (10 Mar 2015)

News

Transcatheter aortic valve replacement (TAVR) is one of the most important advances in cardiovascular medicine in recent years. Although it is associated with significant risks, TAVR can offer some patients a less invasive alternative to traditional aortic valve replacement surgery.  Because of early concerns about potential overuse and misuse of TAVR, many observers have been eagerly…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.